Logo image of PDEX

PRO-DEX INC (PDEX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:PDEX - US74265M2052 - Common Stock

40.22 USD
-0.48 (-1.18%)
Last: 12/5/2025, 8:00:00 PM
Fundamental Rating

5

Overall PDEX gets a fundamental rating of 5 out of 10. We evaluated PDEX against 187 industry peers in the Health Care Equipment & Supplies industry. PDEX has an excellent profitability rating, but there are some minor concerns on its financial health. PDEX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

PDEX had positive earnings in the past year.
PDEX had a negative operating cash flow in the past year.
PDEX had positive earnings in each of the past 5 years.
In multiple years PDEX reported negative operating cash flow during the last 5 years.
PDEX Yearly Net Income VS EBIT VS OCF VS FCFPDEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M -10M

1.2 Ratios

PDEX has a Return On Assets of 17.41%. This is amongst the best in the industry. PDEX outperforms 98.41% of its industry peers.
PDEX has a Return On Equity of 26.96%. This is amongst the best in the industry. PDEX outperforms 97.88% of its industry peers.
Looking at the Return On Invested Capital, with a value of 16.51%, PDEX belongs to the top of the industry, outperforming 96.30% of the companies in the same industry.
PDEX had an Average Return On Invested Capital over the past 3 years of 14.16%. This is significantly above the industry average of 8.81%.
The last Return On Invested Capital (16.51%) for PDEX is above the 3 year average (14.16%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 17.41%
ROE 26.96%
ROIC 16.51%
ROA(3y)10.79%
ROA(5y)11.4%
ROE(3y)17.93%
ROE(5y)20.5%
ROIC(3y)14.16%
ROIC(5y)12.68%
PDEX Yearly ROA, ROE, ROICPDEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

1.3 Margins

With an excellent Profit Margin value of 15.94%, PDEX belongs to the best of the industry, outperforming 92.06% of the companies in the same industry.
In the last couple of years the Profit Margin of PDEX has declined.
The Operating Margin of PDEX (15.36%) is better than 84.13% of its industry peers.
In the last couple of years the Operating Margin of PDEX has declined.
With a Gross Margin value of 28.09%, PDEX is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of PDEX has declined.
Industry RankSector Rank
OM 15.36%
PM (TTM) 15.94%
GM 28.09%
OM growth 3Y9.36%
OM growth 5Y-4.56%
PM growth 3Y7.44%
PM growth 5Y-5.13%
GM growth 3Y-2.11%
GM growth 5Y-4.93%
PDEX Yearly Profit, Operating, Gross MarginsPDEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so PDEX is creating value.
PDEX has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, PDEX has less shares outstanding
The debt/assets ratio for PDEX is higher compared to a year ago.
PDEX Yearly Shares OutstandingPDEX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M
PDEX Yearly Total Debt VS Total AssetsPDEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2.2 Solvency

PDEX has an Altman-Z score of 6.68. This indicates that PDEX is financially healthy and has little risk of bankruptcy at the moment.
PDEX has a better Altman-Z score (6.68) than 82.54% of its industry peers.
PDEX has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
PDEX has a Debt to Equity ratio (0.21) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 6.68
ROIC/WACC1.97
WACC8.39%
PDEX Yearly LT Debt VS Equity VS FCFPDEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M

2.3 Liquidity

A Current Ratio of 3.73 indicates that PDEX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.73, PDEX is in the better half of the industry, outperforming 64.55% of the companies in the same industry.
PDEX has a Quick Ratio of 2.14. This indicates that PDEX is financially healthy and has no problem in meeting its short term obligations.
PDEX has a Quick ratio (2.14) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.73
Quick Ratio 2.14
PDEX Yearly Current Assets VS Current LiabilitesPDEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 107.14% over the past year.
The Earnings Per Share has been growing by 10.96% on average over the past years. This is quite good.
Looking at the last year, PDEX shows a very strong growth in Revenue. The Revenue has grown by 23.65%.
PDEX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.84% yearly.
EPS 1Y (TTM)107.14%
EPS 3Y35.1%
EPS 5Y10.96%
EPS Q2Q%86.67%
Revenue 1Y (TTM)23.65%
Revenue growth 3Y16.57%
Revenue growth 5Y13.84%
Sales Q2Q%24.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-4.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PDEX Yearly Revenue VS EstimatesPDEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
PDEX Yearly EPS VS EstimatesPDEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.61, PDEX is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of PDEX indicates a rather cheap valuation: PDEX is cheaper than 90.48% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of PDEX to the average of the S&P500 Index (26.49), we can say PDEX is valued rather cheaply.
A Price/Forward Earnings ratio of 16.57 indicates a correct valuation of PDEX.
84.66% of the companies in the same industry are more expensive than PDEX, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of PDEX to the average of the S&P500 Index (23.69), we can say PDEX is valued slightly cheaper.
Industry RankSector Rank
PE 12.61
Fwd PE 16.57
PDEX Price Earnings VS Forward Price EarningsPDEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

PDEX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. PDEX is cheaper than 89.42% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.28
PDEX Per share dataPDEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PDEX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.15
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PDEX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PRO-DEX INC

NASDAQ:PDEX (12/5/2025, 8:00:00 PM)

40.22

-0.48 (-1.18%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)01-28 2026-01-28
Inst Owners31.87%
Inst Owner Change-3.05%
Ins Owners36.03%
Ins Owner Change1.64%
Market Cap131.12M
Revenue(TTM)70.23M
Net Income(TTM)11.19M
Analysts82.86
Price Target57.12 (42.02%)
Short Float %10.08%
Short Ratio3.86
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)74.8%
Min EPS beat(2)-24.91%
Max EPS beat(2)174.51%
EPS beat(4)3
Avg EPS beat(4)69.51%
Min EPS beat(4)-24.91%
Max EPS beat(4)174.51%
EPS beat(8)5
Avg EPS beat(8)44.11%
EPS beat(12)7
Avg EPS beat(12)20.2%
EPS beat(16)8
Avg EPS beat(16)16.17%
Revenue beat(2)1
Avg Revenue beat(2)7.28%
Min Revenue beat(2)-4.18%
Max Revenue beat(2)18.74%
Revenue beat(4)2
Avg Revenue beat(4)7.58%
Min Revenue beat(4)-4.18%
Max Revenue beat(4)19.3%
Revenue beat(8)6
Avg Revenue beat(8)12.93%
Revenue beat(12)9
Avg Revenue beat(12)11.32%
Revenue beat(16)12
Avg Revenue beat(16)11.48%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 12.61
Fwd PE 16.57
P/S 1.87
P/FCF N/A
P/OCF N/A
P/B 3.16
P/tB 3.16
EV/EBITDA 10.28
EPS(TTM)3.19
EY7.93%
EPS(NY)2.43
Fwd EY6.04%
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS21.54
BVpS12.73
TBVpS12.73
PEG (NY)N/A
PEG (5Y)1.15
Graham Number30.23
Profitability
Industry RankSector Rank
ROA 17.41%
ROE 26.96%
ROCE 21.27%
ROIC 16.51%
ROICexc 20.85%
ROICexgc 20.86%
OM 15.36%
PM (TTM) 15.94%
GM 28.09%
FCFM N/A
ROA(3y)10.79%
ROA(5y)11.4%
ROE(3y)17.93%
ROE(5y)20.5%
ROIC(3y)14.16%
ROIC(5y)12.68%
ROICexc(3y)16.6%
ROICexc(5y)14.6%
ROICexgc(3y)16.62%
ROICexgc(5y)14.63%
ROCE(3y)18.25%
ROCE(5y)16.34%
ROICexgc growth 3Y23.73%
ROICexgc growth 5Y-8.41%
ROICexc growth 3Y23.84%
ROICexc growth 5Y-8.25%
OM growth 3Y9.36%
OM growth 5Y-4.56%
PM growth 3Y7.44%
PM growth 5Y-5.13%
GM growth 3Y-2.11%
GM growth 5Y-4.93%
F-Score6
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA 0.72
Cap/Depr 73.12%
Cap/Sales 1.3%
Interest Coverage 12.57
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.73
Quick Ratio 2.14
Altman-Z 6.68
F-Score6
WACC8.39%
ROIC/WACC1.97
Cap/Depr(3y)99.37%
Cap/Depr(5y)344.26%
Cap/Sales(3y)1.93%
Cap/Sales(5y)6.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.14%
EPS 3Y35.1%
EPS 5Y10.96%
EPS Q2Q%86.67%
EPS Next Y-4.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.65%
Revenue growth 3Y16.57%
Revenue growth 5Y13.84%
Sales Q2Q%24.43%
Revenue Next Year4.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.16%
EBIT growth 3Y27.48%
EBIT growth 5Y8.65%
EBIT Next Year10.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-206.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-142.63%
OCF growth 3YN/A
OCF growth 5YN/A

PRO-DEX INC / PDEX FAQ

Can you provide the ChartMill fundamental rating for PRO-DEX INC?

ChartMill assigns a fundamental rating of 5 / 10 to PDEX.


Can you provide the valuation status for PRO-DEX INC?

ChartMill assigns a valuation rating of 5 / 10 to PRO-DEX INC (PDEX). This can be considered as Fairly Valued.


Can you provide the profitability details for PRO-DEX INC?

PRO-DEX INC (PDEX) has a profitability rating of 7 / 10.


Can you provide the expected EPS growth for PDEX stock?

The Earnings per Share (EPS) of PRO-DEX INC (PDEX) is expected to decline by -4.43% in the next year.